Baldwin Investment Management, LLC Eli Lilly & CO Transaction History

Baldwin Investment Management, LLC

$802 Million
Q2 2025

A detailed history of Baldwin Investment Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Baldwin Investment Management, LLC holds 9,574 shares of LLY stock, worth $6.08 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

9,574

Previous 9,398 1.87%

Holding current value

$6.08 Million

Previous $7.76 Million 3.84%

% of portfolio

0.93%

Previous 0.96%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$713.71 - $898.95 $125,612 - $158,215	176 Added 1.87%	9,574 $7.46 Million
Q1 2025 May 07, 2025	BUY	$725.72 - $929.72 $370,842 - $475,086	511 Added 5.75%	9,398 $7.76 Million
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $387,597 - $496,787	533 Added 6.38%	8,887 $6.86 Million
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $150,567 - $187,203	195 Added 2.39%	8,354 $7.4 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $6,523 - $8,181	9 Added 0.11%	8,159 $7.39 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $265,305 - $354,941	-448 Reduced 5.21%	8,150 $6.34 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $75,102 - $88,535	-143 Reduced 1.64%	8,598 $5.01 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $121,281 - $167,204	-279 Reduced 3.09%	8,741 $4.7 Million
Q2 2023 Aug 01, 2023	SELL	$350.74 - $468.98 $280,592 - $375,184	-800 Reduced 8.15%	9,020 $4.23 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $620,638 - $728,910	1,998 Added 25.54%	9,820 $3.37 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $216,724 - $252,527	674 Added 9.43%	7,822 $2.86 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $106,139 - $120,957	358 Added 5.27%	7,148 $2.31 Million
Q2 2022 Aug 02, 2022	SELL	$278.73 - $327.27 $159,433 - $187,198	-572 Reduced 7.77%	6,790 $2.2 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $30,509 - $37,915	-130 Reduced 1.74%	7,362 $2.11 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $120,294 - $149,286	535 Added 7.69%	7,492 $2.07 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $66,480 - $81,813	-300 Reduced 4.13%	6,957 $1.61 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $17,152 - $22,186	95 Added 1.33%	7,257 $1.67 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $113,380 - $146,776	690 Added 10.66%	7,162 $1.34 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $16,307 - $21,578	125 Added 1.97%	6,472 $1.09 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $928,058 - $1.07 Million	6,347 New	6,347 $939,000

Others Institutions Holding LLY

# of Institutions

4,396

Shares Held

755M

Call Options Held

10.3M

Put Options Held

10.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $604B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Investment Management, LLC with notifications on news.

Account

Baldwin Investment Management, LLC Eli Lilly & CO Transaction History